Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than expected earnings and revenues for the fourth quarter. The positive outcome
Infographic: A snapshot of Merck’s Q4 2021 earnings
Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than expected earnings and revenues for the fourth quarter. The positive outcome reflects the managements efforts to maintain sustainability through strategic investments in discovery, development and commercialization of medicines and
























